Friday, May 31, 2024

🌎 Bilibili Upgraded, Hormel Foods Upgraded, Sarepta Therapeutics Initiated and more...

Ratings changes for NetApp, Costco Wholesale, Zscaler, Micron Technology, American Superconductor, PayPal, Cracker Barrel Old Country Store and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
Unsubscribe.
MarketBeat Daily Ratings
May 31st, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 

Today's Top Stories
Foot Locker's Quarter Sends Doubters Running
Inflation ticked up in Europe in May. That likely won't stop a central bank rate cut next week
Elon Musk's Final Masterpiece: "X-9840" (Paradigm Press)
Costco Wholesale Can Hit New Highs; A Rebound Is Coming
Oil giant Saudi Aramco offers a second stock tranche worth billions of dollars
Chevron Eyes Hess, Exxon Resists: Here's the Trade
Stock market today: Falling tech stocks drag Wall Street lower again
62 Lawmakers Are Moving Their Money in a Major Way (Altimetry)
Bargain Alert: Amazon and Its 35% Upside
Modi touts India's roaring economy as he seeks reelection, but many feel left behind
AI Is Booming, But Not For These Stocks …Yet
China factory indicator falls in May, suggesting growth has faltered
4 of the Best Stocks for Share Buybacks
Quick Links

Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Asana (NYSE:ASAN) was upgraded by analysts at Piper Sandler from an "underweight" rating to a "neutral" rating. They now have a $16.00 price target on the stock, down previously from $18.00. This represents a 21.2% upside from the current price of $13.20.
  • Bilibili (NASDAQ:BILI) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $18.00 price target on the stock, up previously from $11.90. This represents a 25.7% upside from the current price of $14.32.
  • Century Communities (NYSE:CCS) was upgraded by analysts at Wedbush from an "underperform" rating to a "neutral" rating. They now have a $82.00 price target on the stock. This represents a 2.6% downside from the current price of $84.16.
  • Fifth Third Bancorp (NASDAQ:FITB) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $43.00 price target on the stock. This represents a 15.7% upside from the current price of $37.17.
  • Hormel Foods (NYSE:HRL) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $29.00 price target on the stock, up previously from $28.00. This represents a 6.7% downside from the current price of $31.08.
  • Heartland Financial USA (NASDAQ:HTLF) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $54.00 price target on the stock, up previously from $51.00. This represents a 22.9% upside from the current price of $43.93.
  • Hancock Whitney (NASDAQ:HWC) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $55.00 price target on the stock, up previously from $50.00. This represents a 18.3% upside from the current price of $46.48.
  • Independent Bank Group (NASDAQ:IBTX) was upgraded by analysts at Piper Sandler from an "underweight" rating to an "overweight" rating. They now have a $58.00 price target on the stock, up previously from $38.00. This represents a 25.0% upside from the current price of $46.40.
  • NetApp (NASDAQ:NTAP) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $125.00 price target on the stock, up previously from $95.00. This represents a 6.1% upside from the current price of $117.83.
  • Seacoast Banking Co. of Florida (NASDAQ:SBCF) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $27.00 price target on the stock, up previously from $26.00. This represents a 16.0% upside from the current price of $23.27.
  • UMB Financial (NASDAQ:UMBF) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $98.00 price target on the stock, up previously from $93.00. This represents a 19.0% upside from the current price of $82.35.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Maxeon Solar Technologies (NASDAQ:MAXN) was downgraded by analysts at Northland Securities from a "market perform" rating to an "under perform" rating. They now have a $0.50 price target on the stock, down previously from $7.00. This represents a 70.9% downside from the current price of $1.72.
  • Cactus (NYSE:WHD) was downgraded by analysts at Johnson Rice from a "buy" rating to an "accumulate" rating.The current price is $50.58.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Abacus Life (NASDAQ:ABL) is now covered by analysts at B. Riley. They set a "buy" rating and a $16.00 price target on the stock. This represents a 44.0% upside from the current price of $11.11.
  • AC Immune (NASDAQ:ACIU) is now covered by analysts at BTIG Research. They set a "buy" rating and a $8.00 price target on the stock. This represents a 70.2% upside from the current price of $4.70.
  • Arcellx (NASDAQ:ACLX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $70.00 price target on the stock. This represents a 34.9% upside from the current price of $51.90.
  • Agree Realty (NYSE:ADC) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $60.00 price target on the stock. This represents a 0.2% upside from the current price of $59.86.
  • Allogene Therapeutics (NASDAQ:ALLO) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $11.00 price target on the stock. This represents a 347.2% upside from the current price of $2.46.
  • Apellis Pharmaceuticals (NASDAQ:APLS) is now covered by analysts at Piper Sandler. They set a "neutral" rating and a $46.00 price target on the stock. This represents a 14.9% upside from the current price of $40.04.
  • Ascendis Pharma A/S (NASDAQ:ASND) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $200.00 price target on the stock. This represents a 42.0% upside from the current price of $140.83.
  • BHP Group (NYSE:BHP) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.The current price is $58.90.
  • Beazer Homes USA (NYSE:BZH) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $37.00 price target on the stock. This represents a 30.2% upside from the current price of $28.42.
  • Elevation Oncology (NASDAQ:ELEV) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $10.00 price target on the stock. This represents a 140.4% upside from the current price of $4.16.
  • Essential Properties Realty Trust (NYSE:EPRT) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $30.00 price target on the stock. This represents a 13.1% upside from the current price of $26.52.
  • Federal Signal (NYSE:FSS) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $89.89.
  • Immunome (NASDAQ:IMNM) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $27.00 price target on the stock. This represents a 72.4% upside from the current price of $15.66.
  • Fidelity Southern (NASDAQ:LION) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $14.00 price target on the stock. This represents a 73.1% upside from the current price of $8.09.
  • Landsea Homes (NASDAQ:LSEA) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $14.00 price target on the stock. This represents a 41.0% upside from the current price of $9.93.
  • New Gold (NYSE:NGD) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating on the stock.The current price is $2.15.
  • NNN REIT (NYSE:NNN) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $41.00 price target on the stock. This represents a 0.9% downside from the current price of $41.38.
  • Ocular Therapeutix (NASDAQ:OCUL) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $15.00 price target on the stock. This represents a 150.8% upside from the current price of $5.98.
  • PayPal (NASDAQ:PYPL) is now covered by analysts at New Street Research. They set a "buy" rating and a $80.00 price target on the stock. This represents a 28.9% upside from the current price of $62.06.
  • Quad/Graphics (NYSE:QUAD) is now covered by analysts at Rosenblatt Securities. They set a "buy" rating and a $7.50 price target on the stock. This represents a 63.0% upside from the current price of $4.60.
  • Rubrik (NYSE:RBRK) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $50.00 price target on the stock. This represents a 67.2% upside from the current price of $29.91.
  • Solid Biosciences (NASDAQ:SLDB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $20.00 price target on the stock. This represents a 144.2% upside from the current price of $8.19.
  • Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $157.00 price target on the stock. This represents a 23.6% upside from the current price of $127.00.
  • Vestis (NYSE:VSTS) is now covered by analysts at William Blair. They set a "market perform" rating on the stock.The current price is $12.07.
  • W. P. Carey (NYSE:WPC) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $57.00 price target on the stock. This represents a 1.8% upside from the current price of $56.01.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: These Automated Options are a game changer (Click to Opt-in)
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)